Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.

NCT01248299 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Esophagus

Interventions

DRUG: FU-CDDP
DRUG: LV5FU2-CDDP
DRUG: FOLFOX
DRUG: TPF
OTHER: Best Supportive Care

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]